Treatment of nondermatophyte mold and Candida onychomycosis

Antonella Tosti, Bianca Maria Piraccini, Sandra Lorenzi, Matilde Iorizzo

Research output: Contribution to journalArticle

52 Citations (Scopus)

Abstract

Mold onychomycosis often can be clinically suspected because of the presence of periungual inflammation. Treatment with systemic antifungals is very effective in onychomycosis caused by Aspergillus sp. Scopulariopsis brevicaulis and Fusarium sp. infection are difficult to eradicate and treatment with systemic antifungals should always be associated with topical treatment with nail lacquers. Candida onychomycosis is always a sign of immunodepression. Systemic treatment with itraconazole or fluconazole is usually effective, but relapses are very common.

Original languageEnglish
Pages (from-to)491-497
Number of pages7
JournalDermatologic Clinics
Volume21
Issue number3
DOIs
StatePublished - Jul 1 2003
Externally publishedYes

Fingerprint

Onychomycosis
Candida
Fungi
Scopulariopsis
Lacquer
Itraconazole
Fluconazole
Fusarium
Aspergillus
Nails
Immunosuppression
Inflammation
Recurrence
Infection

ASJC Scopus subject areas

  • Dermatology

Cite this

Treatment of nondermatophyte mold and Candida onychomycosis. / Tosti, Antonella; Piraccini, Bianca Maria; Lorenzi, Sandra; Iorizzo, Matilde.

In: Dermatologic Clinics, Vol. 21, No. 3, 01.07.2003, p. 491-497.

Research output: Contribution to journalArticle

Tosti, Antonella ; Piraccini, Bianca Maria ; Lorenzi, Sandra ; Iorizzo, Matilde. / Treatment of nondermatophyte mold and Candida onychomycosis. In: Dermatologic Clinics. 2003 ; Vol. 21, No. 3. pp. 491-497.
@article{3435a08afd4b4858a2232b4e9640225d,
title = "Treatment of nondermatophyte mold and Candida onychomycosis",
abstract = "Mold onychomycosis often can be clinically suspected because of the presence of periungual inflammation. Treatment with systemic antifungals is very effective in onychomycosis caused by Aspergillus sp. Scopulariopsis brevicaulis and Fusarium sp. infection are difficult to eradicate and treatment with systemic antifungals should always be associated with topical treatment with nail lacquers. Candida onychomycosis is always a sign of immunodepression. Systemic treatment with itraconazole or fluconazole is usually effective, but relapses are very common.",
author = "Antonella Tosti and Piraccini, {Bianca Maria} and Sandra Lorenzi and Matilde Iorizzo",
year = "2003",
month = "7",
day = "1",
doi = "10.1016/S0733-8635(03)00036-6",
language = "English",
volume = "21",
pages = "491--497",
journal = "Dermatologic Clinics",
issn = "0733-8635",
publisher = "W.B. Saunders Ltd",
number = "3",

}

TY - JOUR

T1 - Treatment of nondermatophyte mold and Candida onychomycosis

AU - Tosti, Antonella

AU - Piraccini, Bianca Maria

AU - Lorenzi, Sandra

AU - Iorizzo, Matilde

PY - 2003/7/1

Y1 - 2003/7/1

N2 - Mold onychomycosis often can be clinically suspected because of the presence of periungual inflammation. Treatment with systemic antifungals is very effective in onychomycosis caused by Aspergillus sp. Scopulariopsis brevicaulis and Fusarium sp. infection are difficult to eradicate and treatment with systemic antifungals should always be associated with topical treatment with nail lacquers. Candida onychomycosis is always a sign of immunodepression. Systemic treatment with itraconazole or fluconazole is usually effective, but relapses are very common.

AB - Mold onychomycosis often can be clinically suspected because of the presence of periungual inflammation. Treatment with systemic antifungals is very effective in onychomycosis caused by Aspergillus sp. Scopulariopsis brevicaulis and Fusarium sp. infection are difficult to eradicate and treatment with systemic antifungals should always be associated with topical treatment with nail lacquers. Candida onychomycosis is always a sign of immunodepression. Systemic treatment with itraconazole or fluconazole is usually effective, but relapses are very common.

UR - http://www.scopus.com/inward/record.url?scp=0042515002&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0042515002&partnerID=8YFLogxK

U2 - 10.1016/S0733-8635(03)00036-6

DO - 10.1016/S0733-8635(03)00036-6

M3 - Article

C2 - 12956201

AN - SCOPUS:0042515002

VL - 21

SP - 491

EP - 497

JO - Dermatologic Clinics

JF - Dermatologic Clinics

SN - 0733-8635

IS - 3

ER -